KALV Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Kalvista Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 27 USD Market Closed

Market Cap: $1.4B

	Kalvista Pharmaceuticals Inc NASDAQ:KALV	US
M	Micro Focus International PLC F:M7Q8	UK
A	Activision Blizzard Inc LSE:0H8X	US
	Scandic Hotels Group AB STO:SHOT	SE
	Base Inc OTC:BAINF	JP
C	Compagnie Financiere Richemont SA F:RITN	CH
U	Union Pacific Corp SWB:UNP	US
T	Tegna Inc XMUN:GTT	US
P	Perusahaan Gas Negara Tbk PT SWB:PGB1	ID
	Metro Bank PLC LSE:MTRO	UK
T	TriStar Gold Inc F:7TG	US
	Novo Nordisk A/S BMV:NVON	DK
A	Arcadis NV SWB:HIJ2	NL

Profitability Summary

Kalvista Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

94%

Strong 3Y Average Gross Margin

80%

Negative Operating Margin

-228%

Negative 3Y Average Operating Margin

-2 758%

Negative Net Margin

-223%

Negative 3Y Average Net Margin

-2 709%

Negative Free Cash Flow Margin

-170%

Negative 3Y Average Free Cash Flow Margin

-4 442%

Negative ROE

-167%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-367%

ROIC is Increasing

-351% > 920%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.